Va Fund Parallel Venture Atlas V Net Worth & Insider Trades

Va Fund Parallel Venture Atlas V Alnylam Pharmaceuticals, Inc

As of February 27, 2006

What is Va Fund Parallel Venture Atlas V's Net Worth?

The current estimated net worth of Alnylam Pharmaceuticals, Inc's Va Fund Parallel Venture Atlas V is estimated to be about $30.64M . Va Fund Parallel Venture Atlas V owns about 747,580 units of Alnylam Pharmaceuticals, Inc common stock. In the last 2 years at Alnylam Pharmaceuticals, Inc, Va Fund Parallel Venture Atlas V has sold an estimated value of $2.73M worth.

What is Va Fund Parallel Venture Atlas V's Past Insider Trading?

Va Fund Parallel Venture Atlas V's largest purchase order was 445,000 units , worth over $2.67M on June 2, 2004. Va Fund Parallel Venture Atlas V's largest sale order was 183,000 units , worth over $2.73M on February 27, 2006. In total, Va Fund Parallel Venture Atlas V has made about 4 transactions over 2 years of their time at Alnylam Pharmaceuticals, Inc. Va Fund Parallel Venture Atlas V usually trades in June, with the busiest year in 2004.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

ATLAS VENTURE FUND V LP, VA FUND PARALLEL VENTURE ATLAS V, ATLAS VENTURE ENTREPRENEURS FUND V LP, ATLAS VENTURE FUND VI LP, KG Co GmbH VI Fund Venture Atlas, ATLAS VENTURE ENTREPRENEURS FUND VI LP, ATLAS VENTURE ASSOCIATES V LP, Atlas Venture Associates VI LP

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...

InsideArbitrage

Our partner InsideArbitrage provides a full suite of tools and analysis that allows you to find opportunities from the hundreds of insiders transactions filed by company insiders each week. The service includes the popular Insider Weekends articles that highlight the top 5 insider purchases and sales each week as well as detailed analysis of one company each week. The service also includes several custom screens such as the Double Dipper that includes a list of companies that are buying back their shares while their insiders are independently buying stock on the open market for their own portfolios.

What are Alnylam Pharmaceuticals, Inc's Past Insider Trades?

Alnylam Pharmaceuticals, Inc's most recent insider trade came on August 7, 2023 by Pushkal Garg who sold 7,627 units worth $1.41M . In the last 19 years, insiders at Alnylam Pharmaceuticals, Inc have sold an estimated value of $529.64M and bought an estimated value of $251.63M worth of shares. Insider trading is most common in June, with the busiest year in 2014. The most active traders at the company are John Maraganore, Chief Executive Officer,  Akshay Vaishnaw, President,  and Barry E Greene, President .

ALNYLAM PHARMACEUTICALS, INC. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...